Biotech product

Filgrastim (G-CSF)

An indigenous recombinant protein developed to support white blood cell recovery, part of CEMB's biopharmaceutical portfolio.

Technical Parameters

Therapeutic Class
Recombinant Human G-CSF
Expression Host
Escherichia coli Expression System
Purity Level
> 98% HPLC & SDS-PAGE Verified
Biological Activity
Bone Marrow Granulopoiesis Stimulation
R&D Focus
Indigenous Biosimilar Production

Application Areas

Oncology SupportNeutropenia ManagementBiopharmaceuticalsRecombinant Protein R&D
Biopharmaceuticals & Proteomics Lab

Developing indigenous biosimilar therapeutics and downstream protein purification technologies.

Evidence led

Validated
methodology

CEMB quality

Research
you can trust

Practical impact

From lab
to real life

Original CEMB material for Filgrastim (G-CSF)
Trusted CEMB research & services

Why it matters

Scientific Significance & Real-World Value

Filgrastim is a recombinant form of granulocyte colony-stimulating factor (G-CSF), a protein that stimulates the bone marrow to produce white blood cells.

Developed through CEMB's biopharmaceutical research programme, it reflects the Centre's work on indigenous recombinant therapeutic proteins.

Evidence-led outcome

An indigenous recombinant protein developed to support white blood cell recovery, part of CEMB's biopharmaceutical portfolio.

Core Benefits at a Glance

  • Recombinant G-CSF protein
  • Supports white blood cell production
  • Developed through CEMB's biopharmaceutical research

Partner with CEMB for Molecular Innovation

Driving research. Delivering accuracy. Building a healthier future.

Start a Collaboration